# FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

> **Newsylist Open Intelligence Dossier** · First detected: 2026-08-14 21:29 UTC · Category: Business · Sources: 7 · Current Velocity: 4.63

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| BioSpace | BMS welcomes new multiple myeloma drug as generics batter current portfolio | 2026-08-14 12:09 | [Source Link](https://news.google.com/rss/articles/CBMipwFBVV95cUxPdU45MkR2WUZpV0RJSVJjSm5nSjFwdUZQdWRaSmZMcmg0VVo0ZmN4WDBjTmt0Qk5faUxQNmFkeWJ2LXV4NzZDRUs2c3RUalVoRHp2M0hhQmFZUVBTUVE5Z2pxMWFRLWloSHBaX1lNRmVYOWVTb0k2Nm83SlpYUnc0S3VqMDJaanhBNlRSRkJrYnJkeVFialJ5QWEzU2tTd1daVVZHcDV1MA?oc=5) |
| OncLive | OncLive Weekly News Quiz (8/14/2026): Did You Catch This Week's Myeloma, Lung Cancer, and Polycythemia Vera Updates? | 2026-08-14 12:09 | [Source Link](https://news.google.com/rss/articles/CBMi1wFBVV95cUxPLWoxanRtRUZOMzU3dXZCd2tJRXc3UXBqVlZBWElzTkljb2tpNjZYTHlPUHl3c1hpX2RES012UEVvaVA1MnExd0RPWlF6QXFQWE1JNVZZVzRicWpjWXFnbGF3NnpfS2lMajdmUGF3dUIxcWtvNG9UVHNQdmJJMURQRGNlX2RvaXRTVmZCY2s2LVhuQ3hoamdUdW9PTGFDSkhKQ0F4al9RU0FpYmkyOFFZck91OUlKVnF2eEkwS3JERG1lbXpJdzIxVmNCYUxMbkh0cGFPTnphYw?oc=5) |
| Yahoo Finance | Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Stock Fully Priced? | 2026-08-14 12:09 | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxORlo1UUoySVh3Y0N1cW5oRF9EMmE0Wk1fTnR1RVdHeW94SE51aVdneFVQenRNMndGZWtXVHk3NjRWV0NUMmN5cXc3RnAxVUsyc0VMSHB1WTNFRnhmaG1iTV9Ycm5hMmVhRXpQYUZibjEwZ3JCUG00ZUE3b19INlFaNHdTa1BQa1AwVjJaQklVMS1nWlNT?oc=5) |
| Bristol Myers Squibb | U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse | 2026-08-14 12:09 | [Source Link](https://news.google.com/rss/articles/CBMiowNBVV95cUxQTkFnZUhXUVFZcDhtNGNFRkczZ1BpRWk2eFFUQjRjWDFBU2luWkVBTVR2RUx5cWVvb2NZam1CMlQzYmZ0VnlXV183Q0xXZHY2amR0a2dJV09SeDZ4dkRpb0FrWkdEd0JzdnR3TmxyaFFHZVRwSHNSWG1LcDg1SUpIWERPQjU3VDRGY0VXaGNBSkFLd3dKYXNJOVNMeW9MMDhXX0tCNmRVckFfaGpkcnZsTW1zYUhtNEoxWmtMYm5rZlN0Y1V0RlpOUTU2ZUFqWldxOTlKMVBaWWhnaHl5NURtNkFjTC10Z2R6ZXpZSzZlWWl4Mkd5b1NUVlduQXlLamdzdGg2aEdOLW91TFVCRlZ2TlM5eEMtOWlxRVA2VUVhY3ZxcUk1c0xHR1pMZXFDZnhsX0dybWNGN29VTXB0Rk5PYXlsVWFSZG9nYXZXMEhkNVdlTW5IZlN) |
| reuters.com | US FDA approves Bristol Myers' blood cancer treatment | 2026-08-14 12:09 | [Source Link](https://news.google.com/rss/articles/CBMiqAFBVV95cUxQWjV2Ny1fRVh5Y0RVX0MxVTZMS0xrUWxKUk9reEhUMkZZYm4tWXhCYkY1azBnNkFpVVFwN3BUMkJFZmRPQmVWX0l6RlhEd0RvdFphSkpYd2VuVktxT01HSGZIVDVqN3I1YUo5MGplRGlpSjhWZXdUZV9mMC0zZUFiR0NaUW9yTXpxNGs2elU1alZnSFN4cmRZeFEyREFDbVZEUmZ3aUdpcHI?oc=5) |
| Fierce Pharma | BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod | 2026-08-14 12:09 | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxQazZYUlNiV3g3b1NYdTV1N2Q0MWR1OFNFNFlTblBWMEs5RVlkSUh3eTh6TTZwNE1Pem5QNklqQ3RDY1kwSVRIcmhHZEJRUGd2NXhhVTBMeWJoN1Y0TkpPZjRxb3EyUmtnWnBhek1UQURjM1YzSzdhZ1lVbktKSHlYbEtoMDhGRlJzVm9vRjJxOElPazFkZ3ItSFdqNzFWUFFheUJMRkhRN3J1djJjVDJv?oc=5) |
| STAT | FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class | 2026-08-14 12:09 | [Source Link](https://news.google.com/rss/articles/CBMikgFBVV95cUxPLWpIUjcwZXZoejQ1NVNCeHB0VGl1d3JUODNMb1kyWS16ZXBWTnI2OGtLNUNGdnpKV2l6LUItQmFSamdxSkl5TU52NkVoX0ZtQldGMHduX3pDY3JxRkZ2djl4emhtNGdNY3BLNGRoWWdCUUlxektGV2loVjE2SnRMeFBMcHI2VmVDaEJtb3hpZW1mZw?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-08-14/fda-approves-bristol-multiple-myeloma-treatment-marking-debut-of-novel-drug*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*